CTPS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.759400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.871000E-01
Normal-vs-Stage2
9.191800E-01
Normal-vs-Stage3
1.957440E-01
Normal-vs-Stage4
8.893200E-01
Stage1-vs-Stage2
8.714400E-01
Stage1-vs-Stage3
4.807800E-02
Stage1-vs-Stage4
8.155600E-01
Stage2-vs-Stage3
6.479500E-02
Stage2-vs-Stage4
9.190400E-01
Stage3-vs-Stage4
1.688620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.360600E-01
Normal-vs-AfricanAmerican
5.722000E-01
Normal-vs-Asian
6.197000E-01
Caucasian-vs-AfricanAmerican
3.739200E-01
Caucasian-vs-Asian
2.926600E-01
AfricanAmerican-vs-Asian
8.943000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.833200E-01
Normal-vs-Female
8.296000E-01
Male-vs-Female
1.534810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.620200E-01
Normal-vs-Age(41-60Yrs)
7.065000E-01
Normal-vs-Age(61-80Yrs)
9.264400E-01
Normal-vs-Age(81-100Yrs)
7.535800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.372000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.809200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.507200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.100200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.724960E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.040400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.624000E-01
Normal-vs-Daily Drinker
9.715200E-01
Normal-vs-Weekly Drinker
6.401000E-01
Normal-vs-Occasional Drinker
6.633800E-01
Normal-vs-Social Drinker
7.706000E-01
Non Drinker-vs-Daily Drinker
6.902600E-01
Non Drinker-vs-Weekly Drinker
2.513000E-01
Non Drinker-vs-Occasional Drinker
6.679800E-01
Non Drinker-vs-Social Drinker
8.640400E-01
Daily Drinker-vs-Weekly Drinker
5.585400E-01
Daily Drinker-vs-Occasional Drinker
4.794600E-01
Daily Drinker-vs-Social Drinker
6.164000E-01
Weekly Drinker-vs-Occasional Drinker
1.085360E-01
Weekly Drinker-vs-Social Drinker
1.909570E-01
Occasional Drinker-vs-Social Drinker
8.107000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.328500E-02
Normal-vs-Grade 2
7.937200E-03
Normal-vs-Grade 3
4.143000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.629600E-01
Grade 1-vs-Grade 3
1.472800E-01
Grade 1-vs-Grade 4
1.328500E-02
Grade 2-vs-Grade 3
6.128100E-02
Grade 2-vs-Grade 4
7.937200E-03
Grade 3-vs-Grade 4
4.143000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.485400E-01
Normal-vs-NonDiabetic
8.356800E-01
Diabetic-vs-NonDiabetic
5.082000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.469000E-01
Normal-vs-NoPancreatitis
9.789600E-01
Pancreatitis-vs-NoPancreatitis
4.649900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.533000E-01
Normal-vs-N1
9.309800E-01
N0-vs-N1
6.233400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.460800E-01
Normal-vs-TP53-NonMutant
9.256400E-01
TP53-Mutant-vs-TP53-NonMutant
1.585590E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
